RCT: Effect of Early Treatment with Fluvoxamine on Risk of Emergency Care and Hospitalization Among Patients with COVID-19 – Together Clinical Trials Related: Opinion | Could this be our first effective, inexpensive, widely available outpatient treatment for COVID-19? (It’s fluvoxamine). Preliminary study shows fluvoxamine may reduce clinical deterioration in outpatients with symptomatic COVID-19   Commentary […]

The post [Preprint] RCT: Fluvoxamine reduced the risk for ER visits and hospitalization among patients with Covid-19. appeared first on Links Medicus.